Analyst firms · Guggenheim · DOCS
Guggenheim DOCS price target and rating history
Doximity Inc. (DOCS) · Technology
Guggenheim rates Doximity Inc. (DOCS) Neutral with a $52 price target, as of its latest action on Aug 9, 2023. It has published 3 rating actions on DOCS since April 2022, including 0 upgrades and 1 downgrade. Across 12 firms with a DOCS price target in the last 12 months, the median target is $27.
- Current rating
- Neutral
- Price target
- $52
- Median target, all firms
- $27
- Actions on DOCS
- 3
Guggenheim price target on DOCS
Every Guggenheim rating on DOCS
- Aug 9, 2023
- May 18, 2022
- Apr 7, 2022
How other firms rate DOCS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Underweight | $18 | Aug 10, 2026 |
| BofA Securities | Underperform | $20 | Jun 29, 2026 |
| Barclays | Equal Weight | $20 | May 15, 2026 |
| KeyBanc Capital Markets | Sector Weight | May 14, 2026 | |
| Robert W. Baird | Neutral | $18 | May 14, 2026 |
| BTIG | Neutral | May 14, 2026 | |
| Jefferies | Hold | $19 | May 14, 2026 |
| Truist Securities | Hold | $29 | Apr 20, 2026 |
| Evercore ISI | In-line | $25 | Apr 8, 2026 |
| Canaccord Genuity | Buy | $34 | Feb 9, 2026 |
| RBC Capital Markets | Outperform | $59 | Jan 9, 2026 |
| Morgan Stanley | Overweight | $65 | Dec 15, 2025 |
| Raymond James | Strong Buy | $65 | Nov 21, 2025 |
| BMO Capital Markets | Market Perform | $55 | Nov 13, 2025 |
Questions about Guggenheim and DOCS
- What is Guggenheim's price target for DOCS?
- Guggenheim's latest stated price target for Doximity Inc. (DOCS) is $52, from its action on May 18, 2022.
- What is Guggenheim's rating on DOCS?
- Guggenheim rates DOCS Neutral, a neutral rating, as of Aug 9, 2023.
- When did Guggenheim last change its view on DOCS?
- On Aug 9, 2023, Guggenheim downgrades to Neutral from Buy.
- How does Guggenheim's DOCS target compare with other analysts?
- Across 12 firms with a DOCS price target in the last 12 months, the median target is $27.
More DOCS rating histories
- Wells Fargo7
- BofA Securities6
- Barclays4
- KeyBanc Capital Markets3
- Robert W. Baird3
- BTIG3
- Jefferies3
- Truist Securities3
- Evercore ISI3
- Canaccord Genuity4
- Morgan Stanley8
- Raymond James5
- Goldman Sachs6
- Piper Sandler4
- Leerink Partners4
- Needham6
- J.P. Morgan4
All Guggenheim ratingsDOCS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.